文献速递肝病

症状性人型肝炎病毒感染潜在合并症作为风险因素的调查

Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection.
PubMed 文献 · Aliment Pharmacol Ther · 2017-01-12

一项大型回顾性研究分析512例急性HEV感染病例,215例(42.0%)发生肝衰竭和/或失代偿,45例(8.2%)在3个月内死亡。合并慢性肝病与疾病严重程度相关(OR=8.78,P<0.001),肝外肿瘤、糖尿病、慢性呼吸和肾脏疾病是不良结局的新独立预测因素。

要点

  • 512例急性HEV感染中42.0%发生肝衰竭和/或失代偿,8.2%在3个月内死亡。
  • 合并慢性肝病尤其肝硬化与疾病严重程度相关(OR=8.78,P<0.001)。
  • 肝外肿瘤、糖尿病、慢性呼吸和肾脏疾病为不良结局新独立预测因素。

核心结论

  • 既往合并症包括肿瘤、糖尿病及慢性肝、肺、肾脏疾病是急性HEV感染不良结局尤其是死亡的独立风险因素。

研究设计与样本

  • 大型回顾性研究,分析512例急性HEV感染病例的基线特征、临床结局和实验室数据,采用逻辑回归模型。

主要发现

  • 所有患者均为本土散发性HEV感染,多数为老年人,症状从无症状到严重肝病不等。
  • 215例(42.0%)发生肝衰竭和/或失代偿,45例(8.2%)在3个月内死亡。
  • 近60%患者有潜在慢性肝病,20%为肝硬化,各种肝外潜在合并症常见。
  • 合并慢性肝病尤其肝硬化与疾病严重程度密切相关(OR=8.78,P<0.001),但在严重肝病患者中与死亡率无关。
  • 无四种肝外合并症患者死亡率(4.2%,P<0.001)显著低于有一种(18.5%)或多种合并症(34.5%)患者。

关键数值与推荐

  • 肝衰竭和/或失代偿发生率42.0%(215/512),3个月内死亡率8.2%(45/512)。
  • 慢性肝病与疾病严重程度OR=8.78(P<0.001)。
  • 无肝外合并症死亡率4.2%,一种合并症18.5%,多种合并症34.5%(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptomatic Hepatitis E virus (HEV) infection occurs in few infected subjects, and the risk factors are not completely known. AIM: To explore the risk factors for adverse clinical outcomes in acute HEV infections. METHODS: A large retrospective study was conducted. The baseline characteristics, clinical outcomes, and laboratory data of 512 acute HEV infection cases were analysed using logistic regression models. RESULTS: All patients exhibited autochthonous sporadic HEV infections, and most were elderly. Their symptoms varied from asymptomatic to severe liver diseases. In all, 215 patients (42.0%) had liver failure and/or decompensation, and 45 (8.2%) patients died within 3 months. Nearly 60% of patients had underlying chronic liver diseases (CLDs), 20% were cirrhotic, and various extrahepatic underlying comorbidities were common. The logistic regression analysis revealed that underlying CLDs, especially cirrhosis, were closely associated with disease severity (OR = 8.78, P < 0.001) but not with mortality in patients with severe liver diseases. In addition to the known factors, including an old age, the male gender and CLDs, we identified pre-existing extrahepatic tumours, diabetes, and chronic respiratory and renal diseases as novel independent predictors for adverse clinical outcomes. Importantly, patients without these four extrahepatic comorbidities showed a much lower mortality rate (4.2%, P < 0.001) than patients with one (18.5%) or more comorbidities (34.5%). CONCLUSIONS: Previous comorbidities, including tumours, diabetes, and chronic liver, lung and kidney diseases, were independent risk factors for adverse outcomes, especially mortality, in acute HEV infections. This study provides valuable data for improving the prevention and control of HEV infection.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Zhang S, Chen C, Peng J, et al. Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection. Aliment Pharmacol Ther. 2017. PMID: 28078736. doi:10.1111/apt.13938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。